Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT00492830 · COMPLETED
Trial details
- NCT number
- NCT00492830
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-11-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.